BENZOAK VET® is a liquid containing 20% benzocaine that is applied as an immersion bath treatment. BENZOAK VET® is only available for purchase through Pharma Production AS/Riverence Brood LLC. The primary goal of field studies conducted under INAD #11-740 is to evaluate the efficacy of BENZOAK VET® for use as an anesthetic/sedative in all freshwater finfish, freshwater prawn, and all saltwater finfish. Fish may be treated between 10 – 150 milligram (mg) benzocaine per L for up to 15 minutes. Treatment duration will vary dependent upon species and water temperature. BENZOAK VET® should be applied as a single treatment event. A 72-hour investigational withdrawal period is required for doses up to 100 mg/L and 96-hour for doses between 101 to 150 mg/L, and if other INADs that are authorized by the FDA are used with BENZOAK VET®, then the longest withdrawal time needs to be followed. To participate in the INAD Program for BENZOAK VET® visit thedata collecting site.
Please read the Study Protocol prior to any treatments. It contains the protocol, SDS, and a copy of the forms to be used as a guide for collecting data that will be entered into the online INAD database. The FDA authorization letters for this INAD are currently only available by emailing Bonnie Johnson.
Drug Source
Pharma Production AS/Riverence Brood LLC
PO Box 361
Rochester, WA 98579
United States
- 10 to 150 mg BENZOAK VET®/L (note: BENZOAK VET® is 20% benzocaine – active ingredient). Treatment dose will vary dependent upon species and water temperature.
- Treatment duration is up to 15 minutes. Treatment duration will vary dependent upon species and water temperature.
- BENZOAK VET® should be applied as a single treatment event.
- 72 hours for treatments up to 100 mg/L; 96 hours for treatments between 101 to 150 mg/L.
- No Investigational withdrawal period is required for fish that are not susceptible to legal harvest for a period of 72 or 96 hours post-treatment.
- Euthanized fish must not be sent to slaughter or be otherwise available for food.
- If another INAD is used along with BENZOAK VET® treatments, then the longest withdrawal time must be followed.
- Animals that die during treatment should be disposed of by burial or incineration.
- Investigator must collect data documenting: 1) time to sedation; and 2) time to recovery from sedation. Investigator must also report general fish behavior and any adverse effects relating to treatment.
- Treatment doses and duration cannot exceed 150 mg/L or 15 minutes.
- If fish are released prior to 72 hrs or 96 hrs post-treatment, then a reason for this early release is needed to show how they are not catchable in the Results Report form.
- Investigator must follow all instructions in the Study Protocol for INAD 11-740 regarding drug acquisition and handling, fish treatment and disposition, and data reporting requirements.
- Not for use in transport trucks.
- Drug discharge must be in compliance with local NPDES permitting requirements.